89 related articles for article (PubMed ID: 38622131)
1. The roles of IDH1 in tumor metabolism and immunity.
Ni Y; Shen P; Wang X; Liu H; Luo H; Han X
Future Oncol; 2022 Nov; 18(35):3941-3953. PubMed ID: 36621781
[TBL] [Abstract][Full Text] [Related]
2. Role of the microenvironment in hepatocellular carcinoma development and progression.
Wu SD; Ma YS; Fang Y; Liu LL; Fu D; Shen XZ
Cancer Treat Rev; 2012 May; 38(3):218-25. PubMed ID: 21763074
[TBL] [Abstract][Full Text] [Related]
3. Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression.
Cui Z; Li C; Liu W; Sun M; Deng S; Cao J; Yang H; Chen P
Cell Death Dis; 2024 Apr; 15(4):267. PubMed ID: 38622131
[TBL] [Abstract][Full Text] [Related]
4. IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma.
Lu J; Xu L; Zou Y; Yang RX; Fan Y; Zhang W; Yu D; Yao YG
Med Sci Monit; 2014 Feb; 20():247-54. PubMed ID: 24531386
[TBL] [Abstract][Full Text] [Related]
5. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity.
Ke Y; Bao T; Wu X; Tang H; Wang Y; Ge J; Fu B; Meng X; Chen L; Zhang C; Tan Y; Chen H; Guo Z; Ni F; Lei X; Shi Z; Wei D; Wang L
Biochem Biophys Res Commun; 2017 Jan; 483(1):509-515. PubMed ID: 27998773
[TBL] [Abstract][Full Text] [Related]
6. Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of JAK2/STAT3 pathway.
Liu K; Tian T; Zheng Y; Zhou L; Dai C; Wang M; Lin S; Deng Y; Hao Q; Zhai Z; Dai Z
J Cell Mol Med; 2019 Apr; 23(4):3040-3044. PubMed ID: 30697962
[TBL] [Abstract][Full Text] [Related]
7. Nanodelivery of scutellarin induces immunogenic cell death for treating hepatocellular carcinoma.
Li L; Zou Y; Wang L; Yang L; Li Y; Liao A; Chen Z; Yu Z; Guo J; Han S
Int J Pharm; 2023 Jul; 642():123114. PubMed ID: 37301243
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Cell Proliferation and Metastasis by Scutellarein Regulating PI3K/Akt/NF-κB Signaling through PTEN Activation in Hepatocellular Carcinoma.
Ha SE; Kim SM; Vetrivel P; Kim HH; Bhosale PB; Heo JD; Lee HJ; Kim GS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445559
[TBL] [Abstract][Full Text] [Related]
9. Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-α.
Wu L; Jin Y; Zhao X; Tang K; Zhao Y; Tong L; Yu X; Xiong K; Luo C; Zhu J; Wang F; Zeng Z; Pan D
Cell Metab; 2023 Sep; 35(9):1580-1596.e9. PubMed ID: 37506695
[TBL] [Abstract][Full Text] [Related]
10. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2.
Zhang L; Jiang C; Zhong Y; Sun K; Jing H; Song J; Xie J; Zhou Y; Tian M; Zhang C; Sun X; Wang S; Cheng X; Zhang Y; Wei W; Li X; Fu B; Feng P; Wu B; Shu HB; Zhang J
Nat Cell Biol; 2023 Aug; 25(8):1208-1222. PubMed ID: 37443289
[TBL] [Abstract][Full Text] [Related]
11. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα.
Guo D; Tong Y; Jiang X; Meng Y; Jiang H; Du L; Wu Q; Li S; Luo S; Li M; Xiao L; He H; He X; Yu Q; Fang J; Lu Z
Cell Metab; 2022 Sep; 34(9):1312-1324.e6. PubMed ID: 36007522
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation inhibition by small-molecule targeting USP7 noncatalytic domain for neurodegenerative disease therapy.
Zhang XW; Feng N; Liu YC; Guo Q; Wang JK; Bai YZ; Ye XM; Yang Z; Yang H; Liu Y; Yang MM; Wang YH; Shi XM; Liu D; Tu PF; Zeng KW
Sci Adv; 2022 Aug; 8(32):eabo0789. PubMed ID: 35947662
[TBL] [Abstract][Full Text] [Related]
13. Chip-DSF: A rapid screening strategy for drug protein targets.
Cui Z; Chen P; Li C; Deng S; Yang H
Pharmacol Res; 2022 Aug; 182():106346. PubMed ID: 35809766
[TBL] [Abstract][Full Text] [Related]
14. Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors.
Vaziri-Gohar A; Cassel J; Mohammed FS; Zarei M; Hue JJ; Hajihassani O; Graor HJ; Srikanth YVV; Karim SA; Abbas A; Prendergast E; Chen V; Katayama ES; Dukleska K; Khokhar I; Andren A; Zhang L; Wu C; Erokwu B; Flask CA; Zarei M; Wang R; Rothermel LD; Romani AMP; Bowers J; Getts R; Tatsuoka C; Morton JP; Bederman I; Brunengraber H; Lyssiotis CA; Salvino JM; Brody JR; Winter JM
Nat Cancer; 2022 Jul; 3(7):852-865. PubMed ID: 35681100
[TBL] [Abstract][Full Text] [Related]
15. Reorienting Mechanism of Harderoheme in Coproheme Decarboxylase-A Computational Study.
Liu W; Pang Y; Song Y; Li X; Tan H; Chen G
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269706
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
